أورملوكسيفين (Arabic Wikipedia)

Analysis of information sources in references of the Wikipedia article "أورملوكسيفين" in Arabic language version.

refsWebsite

Global rank Arabic rank

11nih.gov

4^th place

6^th place

10doi.org

2^nd place

5^th place

4web.archive.org

1^st place

3archive.org

6^th place

3^rd place

1wikidata.org

43^rd place

2^nd place

1hindlatex.com

low place

1jhu.edu

699^th place

1,099^th place

1cdri.res.in

low place

1books.google.com

3^rd place

8^th place

archive.org

Lal J، Nitynand S، Asthana OP، Nagaraja NV، Gupta RC (يناير 2001). "Optimization of contraceptive dosage regimen of Centchroman". Contraception. ج. 63 ع. 1: 47–51. DOI:10.1016/S0010-7824(00)00189-X. PMID:11257249.
Singh، M.M. (2001). "Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders". Medicinal Research Reviews. ج. 21 ع. 4: 302–47. DOI:10.1002/med.1011. PMID:11410933.
Singh MM (2001). "Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders". Med Res Rev. ج. 21 ع. 4: 302–47. DOI:10.1002/med.1011. PMID:11410933.

books.google.com

Patil، Robin D. Tribhuwan & Benazir D. (2009). Body image : human reproduction and birth control : a tribal perspective. New Delhi: Discovery Pub. House. ص. 20. ISBN:978-81-8356-388-8. مؤرشف من الأصل في 2019-12-15.

cdri.res.in

"Centchroman". CSIR-CDRI. مؤرشف من الأصل في 2019-02-14.

doi.org

Makker، Annu؛ Tandon، Indu؛ Goel، Madhu Mati؛ Singh، Mastan؛ Singh، Man Mohan (2009). "Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of endometrial receptivity and pinopode development and its relation to fertility and infertility in Indian subjects". Fertility and Sterility. ج. 91 ع. 6: 2298–307. DOI:10.1016/j.fertnstert.2008.04.018. PMID:18675966.
Lal، J (أبريل 2010). "Clinical pharmacokinetics and interaction of centchroman--a mini review". Contraception. ج. 81 ع. 4: 275–80. DOI:10.1016/j.contraception.2009.11.007. PMID:20227542.
Lal J، Nitynand S، Asthana OP، Nagaraja NV، Gupta RC (يناير 2001). "Optimization of contraceptive dosage regimen of Centchroman". Contraception. ج. 63 ع. 1: 47–51. DOI:10.1016/S0010-7824(00)00189-X. PMID:11257249.
Singh، M.M. (2001). "Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders". Medicinal Research Reviews. ج. 21 ع. 4: 302–47. DOI:10.1002/med.1011. PMID:11410933.
Kriplani A، Kulshrestha V، Agarwal N (أغسطس 2009). "Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study". J. Obstet. Gynaecol. Res. ج. 35 ع. 4: 746–52. DOI:10.1111/j.1447-0756.2008.00987.x. PMID:19751337.
Dhar A، Srivastava A (يونيو 2007). "Role of centchroman in regression of mastalgia and fibroadenoma". World J Surg. ج. 31 ع. 6: 1178–84. DOI:10.1007/s00268-007-9040-4. PMID:17431715.
Shelly، W؛ Draper, MW؛ Krishnan, V؛ Wong, M؛ Jaffe, RB (مارس 2008). "Selective estrogen receptor modulators: an update on recent clinical findings". Obstetrical & Gynecological Survey. ج. 63 ع. 3: 163–81. DOI:10.1097/OGX.0b013e31816400d7. PMID:18279543.
Nigam، Manisha؛ Ranjan، Vishal؛ Srivastava، Swasti؛ Sharma، Ramesh؛ Balapure، Anil K. (2008). "Centchroman induces G0/G1 arrest and Caspase-dependent Apoptosis involving Mitochondrial Membrane Depolarization in MCF-7 and MDA MB-231 Human Breast Cancer Cells". Life Sciences. ج. 82 ع. 11–12: 577–90. DOI:10.1016/j.lfs.2007.11.028. PMID:18279897.
Singh MM (2001). "Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders". Med Res Rev. ج. 21 ع. 4: 302–47. DOI:10.1002/med.1011. PMID:11410933.
Lal J (2010). "Clinical pharmacokinetics and interaction of centchroman--a mini review". Contraception. ج. 81 ع. 4: 275–80. DOI:10.1016/j.contraception.2009.11.007. PMID:20227542.

hindlatex.com

"HLL - Product Overview". مؤرشف من الأصل في 2018-11-01.

jhu.edu

reproline.jhu.edu

"نسخة مؤرشفة". مؤرشف من الأصل في 2012-02-05. اطلع عليه بتاريخ 2019-12-12.^{[استشهاد منقوص البيانات]}

nih.gov

pubmed.ncbi.nlm.nih.gov

Makker، Annu؛ Tandon، Indu؛ Goel، Madhu Mati؛ Singh، Mastan؛ Singh، Man Mohan (2009). "Effect of ormeloxifene, a selective estrogen receptor modulator, on biomarkers of endometrial receptivity and pinopode development and its relation to fertility and infertility in Indian subjects". Fertility and Sterility. ج. 91 ع. 6: 2298–307. DOI:10.1016/j.fertnstert.2008.04.018. PMID:18675966.
Lal، J (أبريل 2010). "Clinical pharmacokinetics and interaction of centchroman--a mini review". Contraception. ج. 81 ع. 4: 275–80. DOI:10.1016/j.contraception.2009.11.007. PMID:20227542.
Lal J، Nitynand S، Asthana OP، Nagaraja NV، Gupta RC (يناير 2001). "Optimization of contraceptive dosage regimen of Centchroman". Contraception. ج. 63 ع. 1: 47–51. DOI:10.1016/S0010-7824(00)00189-X. PMID:11257249.
Singh، M.M. (2001). "Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders". Medicinal Research Reviews. ج. 21 ع. 4: 302–47. DOI:10.1002/med.1011. PMID:11410933.
Kriplani A، Kulshrestha V، Agarwal N (أغسطس 2009). "Efficacy and safety of ormeloxifene in management of menorrhagia: a pilot study". J. Obstet. Gynaecol. Res. ج. 35 ع. 4: 746–52. DOI:10.1111/j.1447-0756.2008.00987.x. PMID:19751337.
Dhar A، Srivastava A (يونيو 2007). "Role of centchroman in regression of mastalgia and fibroadenoma". World J Surg. ج. 31 ع. 6: 1178–84. DOI:10.1007/s00268-007-9040-4. PMID:17431715.
Shelly، W؛ Draper, MW؛ Krishnan, V؛ Wong, M؛ Jaffe, RB (مارس 2008). "Selective estrogen receptor modulators: an update on recent clinical findings". Obstetrical & Gynecological Survey. ج. 63 ع. 3: 163–81. DOI:10.1097/OGX.0b013e31816400d7. PMID:18279543.
Nigam، Manisha؛ Ranjan، Vishal؛ Srivastava، Swasti؛ Sharma، Ramesh؛ Balapure، Anil K. (2008). "Centchroman induces G0/G1 arrest and Caspase-dependent Apoptosis involving Mitochondrial Membrane Depolarization in MCF-7 and MDA MB-231 Human Breast Cancer Cells". Life Sciences. ج. 82 ع. 11–12: 577–90. DOI:10.1016/j.lfs.2007.11.028. PMID:18279897.
Singh MM (2001). "Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders". Med Res Rev. ج. 21 ع. 4: 302–47. DOI:10.1002/med.1011. PMID:11410933.
Lal J (2010). "Clinical pharmacokinetics and interaction of centchroman--a mini review". Contraception. ج. 81 ع. 4: 275–80. DOI:10.1016/j.contraception.2009.11.007. PMID:20227542.

pubchem.ncbi.nlm.nih.gov

Ormeloxifene (بالإنجليزية), QID:Q278487

web.archive.org

"HLL - Product Overview". مؤرشف من الأصل في 2018-11-01.
"نسخة مؤرشفة". مؤرشف من الأصل في 2012-02-05. اطلع عليه بتاريخ 2019-12-12.^{[استشهاد منقوص البيانات]}
"Centchroman". CSIR-CDRI. مؤرشف من الأصل في 2019-02-14.
Patil، Robin D. Tribhuwan & Benazir D. (2009). Body image : human reproduction and birth control : a tribal perspective. New Delhi: Discovery Pub. House. ص. 20. ISBN:978-81-8356-388-8. مؤرشف من الأصل في 2019-12-15.

wikidata.org

Ormeloxifene (بالإنجليزية), QID:Q278487